-transparent.png){kind=logo}
Three patients with burns of 35%, 60% and 25% were treated with cyclosporin after the application of allograft skin. Biopsies of the allografts were taken at appropriate intervals. The drug was continued for 3 weeks, 3 months and 3 weeks respectively without ill-effects on the patients. The allografts survived during cyclosporin treatment but were rejected 12 days after cessation of treatment in Case 1 and 5-7 days in Case 2. In Case 3 where a meshed auto/allograft 'sandwich' technique was used, there was no visible evidence of rejection. It is likely that the allograft was replaced by a "creeping substitution" in the sandwich technique. The Langerhans cell is probably not solely responsible for allograft rejection.
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
September 1989,
British journal of plastic surgery,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
July 1989,
British journal of plastic surgery,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
January 1987,
Lancet (London, England),
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
August 1985,
Burns, including thermal injury,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
June 1981,
The Journal of trauma,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
August 1982,
Experimental neurology,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
August 2001,
Veterinary immunology and immunopathology,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
November 1987,
Lancet (London, England),
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
August 1995,
The Annals of thoracic surgery,
J D Frame, and
R Sanders, and
T E Goodacre, and
B D Morgan
March 1963,
The Journal of the International College of Surgeons,
